Skip to main content

3 Result(s)

within Nader Najafian Remove this filter

and

  1. Article

    Open Access

    Pharmacokinetic and Pharmacodynamic Properties of Cemdisiran, an RNAi Therapeutic Targeting Complement Component 5, in Healthy Subjects and Patients with Paroxysmal Nocturnal Hemoglobinuria

    Cemdisiran, an N-acetylgalactosamine (GalNAc) conjugated RNA interference (RNAi) therapeutic, is currently under development for the treatment of complement-mediated diseases by suppressing liver production of co...

    Prajakta Badri, Xuemin Jiang, Anna Borodovsky, Nader Najafian… in Clinical Pharmacokinetics (2021)

    Download PDF (3675 KB) View Article

  2. Article

    Open Access

    In Vitro and In Vivo Studies of IgG-derived Treg Epitopes (Tregitopes): A Promising New Tool for Tolerance Induction and Treatment of Autoimmunity

    Tregitopes are regulatory T cell epitopes derived from immunoglobulin G (IgG) that stimulate CD25+ FoxP3+ T cells to expand. In conjunction with these Tregs, Tregitopes can prevent, treat, and even cure autoimmun...

    Leslie P. Cousens, Nader Najafian, Federico Mingozzi… in Journal of Clinical Immunology (2013)

    Download PDF (229 KB) View Article

  3. No Access

    Chapter

    T Cell Epitopes of Phl p 1, Major Pollen Allergen of Timothy Grass (Phleum pratense)

    Recently several group I grass pollen allergens, such as Phl p 1 from timothy grass (Phleum pratense), some isoforms of Loi p 1 from rye-grass (Lolium perenne), and Sec c 1 from rye (Secale cereale; S. Laffler, u...

    Siegfried Schenk, Heimo Breiteneder, Markus Susani… in New Horizons in Allergy Immunotherapy (1996)